Evidence for a multiple sclerosis epidemic?

B Krone^{1

2}, S V Ramagopalan³

Affiliations

¹ Institute of Virology, University Goettingen, Goettingen, Germany.
² Laboratory Medicine Institute, Kassel, Germany.
³ Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Editorial

B Krone et al. Eur J Neurol. 2013 Mar.

. 2013 Mar;20(3):407.

doi: 10.1111/j.1468-1331.2012.03823.x. Epub 2012 Aug 5.

B Krone^{1

2}, S V Ramagopalan³

¹ Institute of Virology, University Goettingen, Goettingen, Germany.
² Laboratory Medicine Institute, Kassel, Germany.
³ Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

No abstract available

Comment on

Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.
Ajdacic-Gross V, Tschopp A, Schmid M, Bopp M, Gutzwiller F. Ajdacic-Gross V, et al. Eur J Neurol. 2013 Mar;20(3):440-447. doi: 10.1111/j.1468-1331.2012.03802.x. Epub 2012 Jul 11. Eur J Neurol. 2013. PMID: 22779911

1. Ajdacic-Gross V, Tschopp A, Schmid M, Bopp M, Gutzwiller F. Missed epidemics and missing links: international birth cohort trends in multiple sclerosis. Eur J Neurol. 2013; 20: 440-447.
1. Llorca J, Guerrero-Alonso P, Prieto-Salceda D. Mortality trends of multiple sclerosis in Spain, 1951-1997: an age-period-cohort analysis. Neuroepidemiology 2005; 24: 129-134.
1. Jin Y, De Pedro-Cuesta J, Lopez-Abente G, Link H. Birth cohort effects in multiple sclerosis. Ann Epidemiol 2003; 13: 252-260.
1. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010; 9: 727-739.